Study finds that cancer drugs might work better during sleep


A study published Friday in the journal Nature Communications found that the way people's bodies function during the day could interfere with some cancer medicines.
The researchers at the Weitzmann Institute discovered that daytime hormone production "inhibited the work of epidermal growth factor (EGF) receptors," a.k.a. the proteins targeted by some anti-cancer drugs, such as lapatinib, which is used to treat breast cancer, Time reports. The tumor cells use the receptors to "attract nutrients that help them survive," while drugs like lapatinib block the receptors. But the study found that when tumor cells that are attached to steroid hormones in addition to the receptors, some cancer drugs are less effective.
The researchers experimented on mice, treating different groups with lapatinib at various times of day. They found that the mice treated with lapatinib at night had "significantly smaller tumors" than those treated during the day. The scientists speculate that lower nighttime hormone production contributed to the drug's increased effectiveness.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
More research is needed, since the researchers only tested their findings on animals, but the findings could have significance for cancer treatments in the future.
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Meghan DeMaria is a staff writer at TheWeek.com. She has previously worked for USA Today and Marie Claire.
-
Can Texas redistricting save the US House for the GOP?
Today's Big Question Trump pushes a 'ruthless' new plan, but it could backfire
-
'No one should be surprised by this cynical strategy'
Instant Opinion Opinion, comment and editorials of the day
-
Intellectual property: AI gains at creators' expense
Feature Two federal judges ruled that it is fair use for AI firms to use copyrighted media to train bots
-
Australian woman found guilty of mushroom murders
speed read Erin Patterson murdered three of her ex-husband's relatives by serving them toxic death cap mushrooms
-
Combs convicted on 2 of 5 charges, denied bail
Speed Read Sean 'Diddy' Combs was acquitted of the more serious charges of racketeering and sex trafficking
-
Sniper kills 2 Idaho firefighters in ambush
Speed Read A man started a wildfire, then fired a rifle at first responders when they arrived
-
Weinstein convicted of sex crime in retrial
Speed Read The New York jury delivered a mixed and partial verdict at the disgraced Hollywood producer's retrial
-
'King of the Hill' actor shot dead outside home
speed read Jonathan Joss was fatally shot by a neighbor who was 'yelling violent homophobic slurs,' says his husband
-
DOJ, Boulder police outline attacker's confession
speed read Mohamed Sabry Soliman planned the attack for a year and 'wanted them all to die'
-
Assailant burns Jewish pedestrians in Boulder
speed read Eight people from the Jewish group were hospitalized after a man threw Molotov cocktails in a 'targeted act of violence'
-
Driver rams van into crowd at Liverpool FC parade
speed read 27 people were hospitalized following the attack